āagman

Not investment advice. Data and computed figures, for information only.

Sun Pharma Advanced Research Company Ltd

NSE: SPARC
₹188.31
−₹3.50 (−1.82%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹6,023 Cr
CMP
₹188.31
52-wk High / Low
₹289 / 108
P/E
3.8
P/B
4.5
Book Value
₹41.3
Div Yield
0.00%
ROCE
164.0%
ROE
279.0%
Face Value
₹1
D/E
0.42

Price+40.5% over 1Y

āagman read

Computed by āagman
Derived from 4 years and 13 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
5
/ 9
5 of 9 F-score tests passed
Graham Number
₹211
√(22.5 × EPS × book value per share)
ROIC
83.8%
vs 11.2% sector median
Cash flow to profit
−0.15
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+43,500
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
279.0%
ROE × earnings retention ratio
ROE stability
175.6
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.01FII +1.70DII −0.77
Latest quarter vs the previous one
Cash-accrual divergence
143.0%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.1x)
+FII holding rose by 0.1pp over the last year
+PE of 3.8x is below the sector median of 45.9x
Watch-outs
−Price is 34.8% below its 52-week high
−Annualised volatility of 56.2% is in the high band (≥45%)
−Balance-sheet accruals of 143.0% of average assets — earnings are not cash-backed

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales242114171713152710881,85340
Expenses12611311612211011689806274658074
Operating Profit−102−91−103−106−93−103−74−53−52−66−571,773−34
OPM %−425.0%−433.3%−735.7%−623.5%−547.1%−792.3%−493.3%−196.3%−520.0%−825.0%−712.5%95.7%−85.0%
Other Income10864200090−12224
Interest00011135689128
Depreciation3333333333322
Profit before tax−95−86−100−105−96−107−79−61−52−76−801,761−21
Net Profit−95−86−100−106−96−107−80−60−52−76−801,761−21
EPS (₹)−2.94−2.66−3.07−3.26−2.96−3.31−2.45−1.84−1.60−2.34−2.4854.27−0.64

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 4 years + TTM
Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales23976721,8791,909
Expenses453478395280293
Operating Profit−214−402−3231,5991,617
OPM %−89.5%−528.9%−448.6%85.1%84.7%
Other Income11292−213
Interest8293436
Depreciation1213121010
Profit before tax−223−387−3431,5531,584
Net Profit−223−387−3431,5531,584
EPS (₹)−6.86−11.93−10.5547.8648.81

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital32323232—
Reserves48093−2491,306—
Borrowings1661269559—
Other Liabilities302328284273—
Total Liabilities8305153362,171—
Fixed Assets1061089985—
CWIP27445472—
Investments291200—
Other Assets4063621832,014—
Total Assets8305153362,171—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity−69−429−360−239
Cash from Investing Activity−548392158−23
Cash from Financing Activity61742199261
Net Cash Flow−15−3−1

Ratios

As of 31 Mar 2026
4 periods
Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—−108.0−279.0164.0
ROE %———279.0
EPS (₹)−6.86−11.93−10.5547.86
Book Value (₹)———41.3
Face Value (₹)———1
P/E———3.8
Div Yield %———0.00
NPM %−89.2−368.6−463.582.7
OPM %−90.0−532.0−450.085.0
D/E0.030.49—0.42
P/B———4.5

Growth

As of 11 Oct 2026
Compounded sales growth
3 years+99.0%
TTM+2,856.0%
Compounded profit growth
3 years+108.0%
TTM+635.0%
Stock price CAGR
10 years−5.0%
5 years−9.0%
3 years−7.0%
Last year+39.0%
Return on equity
Last year279.0%

Shareholding pattern

As of 30 Jun 2026
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters66.93%66.93%67.47%68.46%68.46%68.46%69.09%65.68%65.68%65.68%65.67%65.68%
FIIs7.33%7.33%6.98%4.47%3.27%2.69%2.38%3.64%3.24%1.45%2.04%3.74%
DIIs1.52%1.52%2.01%1.28%0.30%0.02%0.76%0.63%0.67%1.13%0.88%0.11%
Government————————————
Public24.21%24.21%23.55%25.79%27.96%28.83%27.77%30.04%30.41%31.76%31.41%30.48%
No. of shareholders86,48086,48068,95279,72383,21199,45492,73698,7771,02,7431,42,8641,40,6251,41,992
Change since Sep 2023 (pp)
Promoters −1.25FIIs −3.59DIIs −1.41Public +6.27

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Update On Litigation - Intimation Under Regulation 30 Of SEBI (LODR), 2015Closure of Trading WindowFiling Of Application For Reclassification With Stock ExchangesAnnouncement under Regulation 30 (LODR)-Newspaper Publication
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Jan 2026TranscriptJan 2026PPTDec 2024TranscriptDec 2024PPTApr 2024TranscriptApr 2024RecordingJan 2024TranscriptJan 2024TranscriptJan 2024PPT

Corporate actions

As of 16 Mar 2016
16 Mar 2016RIGHTS Rights 5: 116 At Premium Rs 244/- Per Share—
23 Aug 2012RIGHTSRights 1: 7@ Premium Rs 66 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman